Pathological measurement and staging of residual breast cancer after neoadjuvant chemotherapy.

Harter, Dawn; O'Connor, Siobhan M; Hertel, Johann D; Calhoun, Benjamin C

Harter, Dawn; O'Connor, Siobhan M; Hertel, Johann D; Calhoun, Benjamin C.

Afiliación

Harter D; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
O'Connor SM; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Hertel JD; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Calhoun BC; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Histopathology ; 83(3): 453-464, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37256703

Asunto(s)

Neoplasias de la Mama; Neoplasias de la Mama Triple Negativas; Humanos; Femenino; Neoplasias de la Mama/patología; Terapia Neoadyuvante/métodos; Neoplasias de la Mama Triple Negativas/patología; Neoplasia Residual/tratamiento farmacológico; Neoplasia Residual/patología; Receptor ErbB-2/uso terapéutico; Mama/patología; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Quimioterapia Adyuvante; Estadificación de Neoplasias; Estudios Retrospectivos

Palabras clave

AJCC; RCB; breast; chemotherapy; neoadjuvant; pathology; residual cancer burden; staging

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google